Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 694
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00885079 | Confirmatory Study of OPC-12759 Ophthalmic Suspension | ||
| NCT01955161 | Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil | ||
| NCT07166783 | Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol | ||
| NCT03568383 | Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients | ||
| NCT01122927 | Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features. | ||
| NCT03303079 | Efficacy and Safety of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Chronic Migraine | ||
| NCT05741528 | An Extension Study to a Clinical Study That Will Continue to Evaluate the Effectiveness and Safety of SEP-363856 in People With Schizophrenia That Switch to SEP-363856 From Their From Their Current Antipsychotic Medication | ||
| NCT00130039 | Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II | ||
| NCT01346865 | Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI) | ||
| NCT00072683 | "SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia | ||
| NCT02174822 | A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects | ||
| NCT02013531 | Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms | ||
| NCT00818324 | Long Term Administration Study of OPC-12759 Ophthalmic Suspension | ||
| NCT04812379 | Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP) | ||
| NCT07461220 | Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy | ||
| NCT02250170 | Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor | ||
| NCT04641780 | "Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program" | ||
| NCT05615363 | A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF]) | ||
| NCT02925221 | Canadian Medical Assessment of JINARC™ Outcomes Registry | ||
| NCT02322385 | Clinical Implications of DNA Analysis on ADPKD | ||
| NCT03734302 | The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects | ||
| NCT01649557 | Multicenter, Open-label, Safety and Tolerability Study | ||
| NCT04124614 | Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD | ||
| NCT01001702 | Oral Aripiprazole Open-Label Rollover Study | ||
| NCT05221502 | Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB | ||
| NCT00544869 | A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure) | ||
| NCT04150146 | To Evaluate Food Effect on the Pharmacokinetics of Rebamipide in Healthy Volunteers | ||
| NCT01131351 | Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis | ||
| NCT00665366 | Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder | ||
| NCT03896945 | Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia | ||
| NCT00576706 | PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity | ||
| NCT00216749 | Efficacy and Safety of Cilostazol for the Indication of CSPS | ||
| NCT00216723 | Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar Disorder | ||
| NCT06926829 | A Long-term Trial of EB-1020 in Adult Patients With ADHD | ||
| NCT02108288 | Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers | ||
| NCT00797966 | Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder | ||
| NCT00706589 | Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder | ||
| NCT00092508 | CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission | ||
| NCT00876343 | Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder | ||
| NCT00504426 | Dose-ranging Trial of OPC-249 Powder Inhalation in Patients With Pain Due to Osteoporosis | ||
| NCT02168920 | Aripiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type | ||
| NCT02548845 | An Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in Spain | ||
| NCT01909466 | Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia | ||
| NCT04150172 | To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers | ||
| NCT01628926 | A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients | ||
| NCT02476409 | Tolvaptan For Worsening Outpatient Heart Failure: Role of Copeptin In Identifying Responders | ||
| NCT03487198 | The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder | ||
| NCT00731549 | Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia | ||
| NCT03427892 | Brexpiprazole for Bipolar Depression | ||
| NCT04782258 | A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD) |
